
Eric Scott Mccall
Examiner (ID: 2073, Phone: (571)272-2183 , Office: P/2856 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2616, 2856, 2214, 2855, 2605, 2899 |
| Total Applications | 2502 |
| Issued Applications | 2207 |
| Pending Applications | 106 |
| Abandoned Applications | 220 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6144844
[patent_doc_number] => 20110130432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Heterocyclic Carboxamides For Use As Thrombin Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/000637
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21803
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130432.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000637
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000637 | Heterocyclic Carboxamides For Use As Thrombin Inhibitors | Jun 21, 2009 | Abandoned |
Array
(
[id] => 6595339
[patent_doc_number] => 20100048557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'Triazolopyridine JAK Inhibitor Compounds and Methods'
[patent_app_type] => utility
[patent_app_number] => 12/488312
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35013
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048557.pdf
[firstpage_image] =>[orig_patent_app_number] => 12488312
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/488312 | Triazolopyridine JAK Inhibitor Compounds and Methods | Jun 18, 2009 | Abandoned |
Array
(
[id] => 4575214
[patent_doc_number] => 07855222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-21
[patent_title] => 'Methods for treating a disease in which Rho kinase is involved'
[patent_app_type] => utility
[patent_app_number] => 12/456652
[patent_app_country] => US
[patent_app_date] => 2009-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 53373
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/855/07855222.pdf
[firstpage_image] =>[orig_patent_app_number] => 12456652
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/456652 | Methods for treating a disease in which Rho kinase is involved | Jun 18, 2009 | Issued |
Array
(
[id] => 6128143
[patent_doc_number] => 20110086889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'TETRAZOLE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/996840
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28203
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086889.pdf
[firstpage_image] =>[orig_patent_app_number] => 12996840
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/996840 | TETRAZOLE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS | Jun 9, 2009 | Abandoned |
Array
(
[id] => 5987815
[patent_doc_number] => 20110098473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'NOVEL TRANSITION METAL COMPLEXES AND USE THEREOF IN ORGANIC LIGHT EMITTING DIODES - III'
[patent_app_type] => utility
[patent_app_number] => 12/997378
[patent_app_country] => US
[patent_app_date] => 2009-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8724
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20110098473.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997378
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997378 | Transition metal complexes and use thereof in organic light emitting diodes—III | Jun 8, 2009 | Issued |
Array
(
[id] => 4470345
[patent_doc_number] => 07943648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same'
[patent_app_type] => utility
[patent_app_number] => 12/478954
[patent_app_country] => US
[patent_app_date] => 2009-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5681
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943648.pdf
[firstpage_image] =>[orig_patent_app_number] => 12478954
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/478954 | Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same | Jun 4, 2009 | Issued |
Array
(
[id] => 6187608
[patent_doc_number] => 20110171138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'SUBSTANTIALLY PURE DEFERASIROX AND PROCESSES FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/995795
[patent_app_country] => US
[patent_app_date] => 2009-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7668
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171138.pdf
[firstpage_image] =>[orig_patent_app_number] => 12995795
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995795 | SUBSTANTIALLY PURE DEFERASIROX AND PROCESSES FOR THE PREPARATION THEREOF | Jun 1, 2009 | Abandoned |
Array
(
[id] => 5534348
[patent_doc_number] => 20090234136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-17
[patent_title] => 'SYNTHESIS OF PHOSPHONO-SUBSTITUTED PORPHYRIN COMPOUNDS FOR ATTACHMENT TO METAL OXIDE SURFACES'
[patent_app_type] => utility
[patent_app_number] => 12/473438
[patent_app_country] => US
[patent_app_date] => 2009-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20282
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20090234136.pdf
[firstpage_image] =>[orig_patent_app_number] => 12473438
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/473438 | Synthesis of phosphono-substituted porphyrin compounds for attachment to metal oxide surfaces | May 27, 2009 | Issued |
Array
(
[id] => 6121404
[patent_doc_number] => 20110077279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'ANGIOTENSIN II RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/995640
[patent_app_country] => US
[patent_app_date] => 2009-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10556
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20110077279.pdf
[firstpage_image] =>[orig_patent_app_number] => 12995640
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995640 | ANGIOTENSIN II RECEPTOR ANTAGONISTS | May 17, 2009 | Abandoned |
Array
(
[id] => 6113461
[patent_doc_number] => 20110190301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'SUBSTITUTED CYCLOPENTANES OR CYCLOPENTANONES AS THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/992229
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18106
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190301.pdf
[firstpage_image] =>[orig_patent_app_number] => 12992229
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992229 | Substituted cyclopentanes or cyclopentanones as therapeutic agents | May 12, 2009 | Issued |
Array
(
[id] => 8257731
[patent_doc_number] => 08207208
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-26
[patent_title] => 'Angiotensin II receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 12/992300
[patent_app_country] => US
[patent_app_date] => 2009-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11293
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12992300
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/992300 | Angiotensin II receptor antagonists | May 5, 2009 | Issued |
Array
(
[id] => 5984822
[patent_doc_number] => 20110097413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'SOLID STATE FORMS OF DEFERASIROX SALTS AND PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/988836
[patent_app_country] => US
[patent_app_date] => 2009-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11170
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097413.pdf
[firstpage_image] =>[orig_patent_app_number] => 12988836
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/988836 | SOLID STATE FORMS OF DEFERASIROX SALTS AND PROCESS FOR THE PREPARATION THEREOF | Apr 19, 2009 | Abandoned |
Array
(
[id] => 5496443
[patent_doc_number] => 20090264471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Compounds, Compositions and Methods Comprising Triazole Derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/426860
[patent_app_country] => US
[patent_app_date] => 2009-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26053
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264471.pdf
[firstpage_image] =>[orig_patent_app_number] => 12426860
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/426860 | Compounds, Compositions and Methods Comprising Triazole Derivatives | Apr 19, 2009 | Abandoned |
Array
(
[id] => 8592010
[patent_doc_number] => 08349886
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-08
[patent_title] => 'Nitrogenated 5-membered heterocyclic compound'
[patent_app_type] => utility
[patent_app_number] => 12/937820
[patent_app_country] => US
[patent_app_date] => 2009-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31725
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937820
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937820 | Nitrogenated 5-membered heterocyclic compound | Apr 14, 2009 | Issued |
Array
(
[id] => 5527817
[patent_doc_number] => 20090197894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'NICOTINAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/423432
[patent_app_country] => US
[patent_app_date] => 2009-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28528
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197894.pdf
[firstpage_image] =>[orig_patent_app_number] => 12423432
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/423432 | NICOTINAMIDE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | Apr 13, 2009 | Abandoned |
Array
(
[id] => 9046896
[patent_doc_number] => 08541450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines'
[patent_app_type] => utility
[patent_app_number] => 12/413851
[patent_app_country] => US
[patent_app_date] => 2009-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3912
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12413851
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/413851 | Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines | Mar 29, 2009 | Issued |
Array
(
[id] => 6571987
[patent_doc_number] => 20100234619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'PREPARATION OF (S)-(+)-N-METHYL-3-(1-NAPHTHYLOXY)-3-(2-THIENYL) PROPYLAMINE USING OPTICALLY ACTIVE METHYLHYDROXYLAMINOPROPANOL DERIVATIVE AS AN INTERMEDIATE'
[patent_app_type] => utility
[patent_app_number] => 12/402740
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1959
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234619.pdf
[firstpage_image] =>[orig_patent_app_number] => 12402740
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/402740 | Preparation of (S)-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl) propylamine using optically active methylhydroxylaminopropanol compound as an intermediate | Mar 11, 2009 | Issued |
Array
(
[id] => 6007986
[patent_doc_number] => 20110060017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'NOVEL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 12/921995
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6049
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20110060017.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921995
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921995 | NOVEL 1,2,3-TRIAZOLE DERIVATIVES USEFUL AS MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | Mar 8, 2009 | Abandoned |
Array
(
[id] => 8749521
[patent_doc_number] => 08415354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-09
[patent_title] => 'Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme'
[patent_app_type] => utility
[patent_app_number] => 12/390329
[patent_app_country] => US
[patent_app_date] => 2009-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 69045
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12390329
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/390329 | Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme | Feb 19, 2009 | Issued |
Array
(
[id] => 6024348
[patent_doc_number] => 20110052674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'ANGIOTENSIN II RECEPTOR BLOCKER DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/866688
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26018
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866688
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866688 | ANGIOTENSIN II RECEPTOR BLOCKER DERIVATIVES | Feb 18, 2009 | Abandoned |